17
Feb
2026
17
Feb
2026
Polynucleotides are now a mainstream part of regenerative aesthetics in the UK, and with that shift has come a steady rise in patient questions about how these treatments work, who they are suitable for, and how they fit alongside injectables, devices, and medical-grade skincare. Clinics that make it easy for patients to find clear, credible information are increasingly the ones that build trust, smoother consultations, and stronger enquiry pipelines.
To support you with this, we have now published a comprehensive Polynucleotides FAQ on ConsultingRoom.com. This is not just a patient resource; it is designed to work directly with your profile on our platform.
If you are already offering polynucleotides, you can link to this new FAQ from within your ConsultingRoom control panel. Once linked, your clinic will automatically appear on our UK-wide Polynucleotides search, making it easier for informed patients to find you when they are actively researching this treatment.
You can view the search page here:
https://www.consultingroom.com/clinics/treatments/polynucleotides
The FAQ provides a consistent, consumer-friendly reference that aligns with UK best practice and uses clear, balanced language. Instead of recreating this from scratch on your site, you can connect to a trusted, centralised resource while increasing your visibility to patients already searching for polynucleotide providers.
If polynucleotides are not currently part of your treatment menu, this FAQ is also a useful starting point for you and your team. It outlines indications, expectations, and common questions in a clear, practical way, making it easier to assess whether this modality fits your clinic’s clinical philosophy.
Many forward-thinking clinics are building treatment plans around skin quality, regeneration, and longevity, not just correction. Polynucleotides, particularly Plinest PN-HPT, sit squarely within this approach.
Clinically, they are versatile across a wide range of indications, including:
They promote fibroblast stimulation, tissue repair, hydration, and improved elasticity, while also reducing downtime and promoting healing after energy-based treatments.
From a commercial perspective, clinics often find that polynucleotides encourage repeat course treatments, improve patient satisfaction, and support longer-term treatment planning rather than one-off appointments.
If you are considering adding polynucleotides to your offering, we recommend speaking with our partner DermaFocus, a specialist distributor with strong clinical support and training infrastructure.
Their flagship product, Plinest®, is widely used in UK clinics and is positioned as a foundational regenerative therapy rather than a trend treatment. This makes it easier to integrate across multiple treatment pathways rather than treating it as a standalone add-on.
Working with DermaFocus gives you access to practical support in areas that matter day-to-day, including:
Their team focuses on helping clinics implement polynucleotides thoughtfully, safely, and commercially sensibly, rather than simply supplying product.
You can learn more about DermaFocus here:
https://dermafocus.co.uk/
And about Plinest PN-HPT here:
https://dermafocus.co.uk/polynucleotide/
If you already use polynucleotides, take five minutes this week to add the new ConsultingRoom FAQ link to your patient-facing materials. It is a small action that strengthens your educational offering immediately.
If you are not yet offering polynucleotides, review the FAQ with your clinical team, then book a conversation with DermaFocus to explore how Plinest® could fit into your existing protocols.
Polynucleotides are becoming a core pillar of regenerative aesthetics in the UK. With the right information and the right partner, you can adopt them confidently, compliantly, and commercially.
Read it? Loved it? Want to share it?
